Education
About Us
Working with TipRanks
Follow Us
JD Health International, Inc. (HK:6618)
:6618
Total Valuation
JD Health International, Inc. has a market cap or net worth of HK$157.33B. The enterprise value is HK$106.67B.
Market CapHK$157.33B
Enterprise ValueHK$106.67B
Share Statistics
JD Health International, Inc. has 3,210,775,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,210,775,100
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
JD Health International, Inc.’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 5.39%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)5.39%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee20.07M
Profits Per Employee1.47M
Employee Count3,564
Asset Turnover0.88
Inventory Turnover7.84
Valuation Ratios
The current PE Ratio of JD Health International, Inc. is 30.1. JD Health International, Inc.’s PEG ratio is 1.20.
PE Ratio30.1
PS Ratio2.20
PB Ratio2.62
Price to Fair Value2.62
Price to FCF0.00
Price to Operating Cash Flow13.40
PEG Ratio1.20
Income Statement
In the last 12 months, JD Health International, Inc. had revenue of 71.54B and earned 5.24B in profits. Earnings per share was 1.65.
Revenue71.54B
Gross Profit17.73B
Operating Income3.70B
Pretax Income5.87B
Net Income5.24B
EBITDA3.97B
Earnings Per Share (EPS)1.65
Cash Flow
In the last 12 months, operating cash flow was 10.31B and capital expenditures -4.10B, giving a free cash flow of 6.21B billion.
Operating Cash Flow10.31B
Free Cash Flow6.21B
Free Cash Flow per Share1.93
Dividends & Yields
JD Health International, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.45
52-Week Price Change47.15%
50-Day Moving Average58.74
200-Day Moving Average57.19
Relative Strength Index (RSI)35.51
Average Volume (3m)7.60M
Important Dates
JD Health International, Inc. upcoming earnings date is Aug 13, 2026, TBA (Confirmed).
Last Earnings DateMar 5, 2026
Next Earnings DateAug 13, 2026
Ex-Dividend Date―
Financial Position
JD Health International, Inc. as a current ratio of 2.72, with Debt / Equity ratio of 1.06%
Current Ratio2.72
Quick Ratio2.39
Debt to Market Cap<0.01
Net Debt to EBITDA-7.85
Interest Coverage Ratio342.22
Taxes
In the past 12 months, JD Health International, Inc. has paid 645.73M in taxes.
Income Tax645.73M
Effective Tax Rate0.11
Enterprise Valuation
JD Health International, Inc. EV to EBITDA ratio is 31.85, with an EV/FCF ratio of 0.00.
EV to Sales1.77
EV to EBITDA31.85
EV to Free Cash Flow0.00
EV to Operating Cash Flow12.73
Balance Sheet
JD Health International, Inc. has HK$47.00B in cash and marketable securities with HK$636.29M in debt, giving a net cash position of HK$46.36B billion.
Cash & Marketable SecuritiesHK$47.00B
Total DebtHK$636.29M
Net CashHK$46.36B
Net Cash Per ShareHK$14.44
Tangible Book Value Per ShareHK$19.00
Margins
Gross margin is 24.78%, with operating margin of 5.17%, and net profit margin of 7.32%.
Gross Margin24.78%
Operating Margin5.17%
Pretax Margin8.21%
Net Profit Margin7.32%
EBITDA Margin5.55%
EBIT Margin5.17%
Analyst Forecast
The average price target for JD Health International, Inc. is HK$75.80, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$75.80
Price Target Upside25.71% Upside
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast18.56%
EPS Growth Forecast79.54%